Caxton Associates (UK)’s Innospec IOSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,726
Closed -$345K 862
2026
Q1
$345K Buy
+4,726
New +$368K 0.01% 573
2025
Q3
Sell
-5,116
Closed -$430K 831
2025
Q2
$430K Sell
5,116
-1,066
-17% -$93.3K 0.01% 462
2025
Q1
$586K Buy
+6,182
New +$654K 0.02% 440

Other funds holding IOSP

Caxton Associates (UK)'s IOSP Position: Q2 2026 in Review

Caxton Associates (UK) sold out of Innospec (IOSP) in Q2 2026, closing a stake of 4,726 shares — an estimated $345K sold.

Caxton Associates (UK) first reported a position in IOSP in Q1 2025 and held it in 3 quarters. The position peaked at $586K in Q1 2025. 282 funds tracked by Wall St. Rank hold IOSP as of Q2 2026.

  • Caxton Associates (UK) reported no remaining Innospec position as of Q2 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 4,726 Innospec shares in Q2 2026, an estimated $345K.
  • Caxton Associates (UK) first reported a position in Innospec in Q1 2025 and held it in 3 quarters.
  • Caxton Associates (UK)'s Innospec position peaked at $586K in Q1 2025.
  • 282 funds tracked by Wall St. Rank held Innospec as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.